On 26-27 September Vilnius is hosting Life Sciences Baltics 2018 at the Lithuanian Exhibition and Congress Centre LITEXPO. As the only international forum in the Baltics for biotechnology, pharmaceutical and medical device experts from around the world, the conference gives participants a unique platform to explore new innovative horizons, share best practices, and grow their professional networks. Moreover, the global recognition the city’s Life Sciences sector has received, together with its comparatively rapid growth, make it an ideal spot for the event.
“We are happy to see this event return to Lithuania’s capital and are eagerly welcoming its extensive network to the city. Vilnius is an up-and-coming meetings and events destination, which is something we are excited about, but it’s even more inspiring to see an event in Vilnius that coincides with one of our key sectors. We hope the delegates have a productive two days and get a chance to experience Vilnius hospitality first hand,” says Inga Romanovskiene, Director of Go Vilnius, the official development agency of the City of Vilnius.
With over 50 speakers set to lead discussions and give presentations on topics like laser applications in life sciences, diagnostic technologies, digital health, stem cells, 3D printing in medicine and so much more, the 1,500 key sectors players in attendance will have their agendas packed over the course of the two-day event. Notable speakers include Lithuania’s President Dalia Grybauskaitė, who will deliver the conference’s opening address, and 2012 Nobel Prize Winner in Chemistry, Professor Brian Kobilka, who will follow with a keynote speech.
Hosted by Enterprise Lithuania, this Life Sciences event comes off the heels of this summer’s successful CRISPR 2018 conference, a four-day meeting co-hosted by Vilnius University’s Institute of Biotechnology where leading scientists treated advanced methodology, strategies and the timeline to maximise the power of genome editing.
The conference reflects the Life Sciences sector’s rapid development in Lithuania. Leading the way is Vilnius University’s Joint Life Sciences Centre (JLSC). The centre serves as a hub that combines the university’s Biochemistry, Biotechnology and Natural Sciences faculties in a new state-of-the-art building. The JLSC undertakes research, education and technological development across a wide range of science disciplines, and also houses a Bioincubator, making facilities available to local startups to effectively boost the BioTech sector in Vilnius.
The work being put into the city’s Life Sciences sector has not gone unnoticed, either. This year, the US magazine Scientific American Worldview ranked Lithuania’s biotechnology sector 16th globally, which is a jump of 18 spots compared to the country’s ranking just five years ago. The magazine noted that the sector is responsible for almost 1.5% of the country’s GDP, which is about 10 times the EU average. The Scientific American Worldview also pointed to Lithuania’s capacity for innovation within the sector, the government’s attempts to create a favourable environment for growth, and the rapid rate at which biotechnology and pharmaceutical research and production are growing as reasons behind the favourable ranking.
Find out more about Life Sciences Baltics 2018 on the event website: https://lsb2018.com/